Fertility preservation in non-cancer patients

Principles and Practice of Fertility Preservation

Volumn , Issue , 2011, Pages 23-34

  Domingo, Javier ^a   Cobo, Ana ^b   Sánchez, María ^c   Pellicer, Antonio ^c  

^a Universidad Las Palmas   (Spain)

^b INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927118510     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511921896.006     Document Type: Chapter

References (75)

1. National Cancer Institute, Division of Cancer Control and Population Sciences. Surveillance, Epidemiology and End Results Program, 1975–2003. Bethesda MD: National Cancer Institute, 2006.
2. Thomson A, Critchley H and Wallace W. Fertility and progeny. Eur J Cancer2002; 38: 1634–44.
3. Linet M, Ries L, Smith MA et al.Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst1999; 91: 1051–8.
4. Blumenfeld Z and Eckman A. Tratamientos oncológicos y supervivencia folicular. In: Schneider J, García-Velasco JA (eds.), Cáncer y reproducción. Cuadernos de Medicina Reproductiva. Madrid: Adalia farma, 2005: pp. 33–43.
5. Gidoni Y, Holzer H, Tulandi T et al.Fertility preservation in patients with non-oncological conditions. Reprod Biomed Online2008; 16: 792–800.
6. Cobo A, Bellver J, Domingo J et al.New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online2008; 17: 68–72.
7. Meseguer M, Molina N, García-Velasco JA et al.Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril2006; 85: 640–5.
8. Kuwayama M, Vajta G, Kato O et al.Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online2005; 11: 300–8.
9. Silber SJ, Derosa M, Pineda J et al.A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod2008; 23: 1531–7.
10. Blumenfeld Z. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy. Minerva Endocrinol2007; 32: 23–34.
11. Jurema MW and Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril2006; 86: 1277–91.
12. Tulandi T, Huang JY and Tan SL. Preservation of female fertility: an essential progress. Obstet Gynecol2008; 112: 1160–72.
13. Bines J, Oleske DM and Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol1996; 14: 1718–29.
14. Larsen EC, Müller J, Schmiegelow K et al.Reduced ovarian function in a long-term survivors of radiation and chemotherapy-treated childhood cancer. J Clin Endocrinol Met2003; 88: 5307–14.
15. Poniatowski BC, Grimm P and Cohen G. Chemoterapy-induced menopause: a literature review. Cancer Invest2001; 19: 641–8.
16. Meirow D and Nugent D.The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update2001; 7: 535–43.
17. Meirow D, Epstein M, Lewis H et al.Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod2001; 16: 632–7.
18. Sonmezer M and Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist2006; 11: 422–34.
19. Warne GL, Fairley KF, Hobbs JB et al.Cyclophosphamide-induced ovarian failure. N Engl J Med1973; 289: 1159–62.
20. Marcello MF, Nuciforo G, Romeo R et al.Structural and ultrastructural study of the ovary in childhood leukemia after succesful treatment. Cancer1990; 66: 2099–104.
21. Familiari G, Caggiati A, Nottola SA et al.Ultrastructure of human primordial follicles after combination chemotherapy for Hodgkin’s disease. Hum Reprod1993; 8: 2080–7.
22. Meirow D, Dor J, Kaufman B et al.Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod2007; 22: 1626–33.
23. Anderson RA, Themmen AP, Al-Qahtani A et al.The effects of chemotherapy and long term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum reprod2006; 21: 2583–92.
24. Wallace WH, Thomson AB and Kelsey TW. The radiosensitivity of human oocyte. Hum Reprod2003; 18: 117–21.
25. Howell SJ and Shalet S. Gonadal damage from chemotherapy and radiotherpy. Endocrinol Metab Clin1998; 27: 927–43.
26. Patrick K, Wallace WH and Critchley H. Late reproductive effects of cancer treatment in female survivors of childhood malignancy. Curr Obstet Gynecol2003; 13: 369–72.
27. Goynumer G, Kayabasoglu F, Aydogdu S et al.The effect of tubal sterilization through electrocoagulation on the ovarian reserve. Contraception2009; 80: 90–4.
28. Hernández-Díaz S, Werler MM, Walker AM et al.Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med2000; 343: 1608–14.
29. Alonso V, Linares V, Bellés M et al.Sulfasalazine induced oxidative stress: a possible mechanism of male infertility. Reprod Toxicol2009; 27: 35–40.
30. Ostensen, Khamashta M, Lockshin M et al.Anti-inflammatory and immunosupressive drugs and reproduction. Arthritis ResTher2006; 8: 209.
31. Martini AC, Molina RI, Tissera AD et al.Analysis of semen from patients chronically treated with low or moderate doses of aspirin like drugs. Fertil Steril2003; 80: 221–2.
32. Huang JY, Tulandi T, Holzer H et al.Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril2008; 89: 567–72.
33. Kuwayama M, Vajta G, Kato O et al.Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online2005; 11: 300–8.
34. Tao T and del Valle A. Human oocyte and ovarian tissue cryopreservation and its application. J Assist Reprod Genet2008; 25: 287–96.
35. Cobo A, Kuwayama M, Pérez S et al.Comparison of concomitant outcome achieved with fresh and cryopreserved oocytes vitrifyed by the Cryotop method. Fertil Steril2008; 89: 1657–64.
36. Chian RC, Huang JY, Tan SL et al.Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online2008; 16: 608–10.
37. The Ethics Committee of the American Society for ReproductiveMedicine. Fertility preservation and reproduction in cancer patients. Fertil Steril2005; 83: 1622–8.
38. Sánchez M, Alamá P, Gadea B et al.Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod2007; 22: 786–91.
39. Nugent D, Meirow D, Brook PF et al.Transplantation in reproductive medicine: previous experience, present knowledge and future prospects. Hum Reprod Updat1997; 3: 267–80.
40. Dolmans M, Donnez J, Camboni A et al.IVF outcome in patients with orthotopically transplanted ovarian tissue. Hum Reprod2009; 24: 2778–87.
41. Andersen CY, Rosendahl M, Byskov AG et al.Successful autotransplantation of frozen/thawed ovarian tissue. Hum Reprod2008; 23: 2266–72.
42. Robertson JA. Ethical issues in ovarian transplantation and donation. Fertil Steril2000; 73: 443–6.
43. American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril2005; 83: 1622–8.
44. Sánchez-Serrano M, Crespo J, Mirabet V et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril 2009, Oct 30. [Epub ahead of print]
45. Sonmezer M and Oktay K. Fertility preservation in female patients. Hum. Reprod Update2004; 10: 251–66.
46. Bisharah M and Tulandi T. Laparoscopic preservation of ovarian function: un underused procedure. Am J Obstet Gynecol2003; 188: 367–70.
47. Bromer JG and Patrizio P. Preservation and postponement of female fertility. Placenta2008; 29 (Suppl. B): 200–5.
48. Oktay K, Sönmezer M, Oktem O et al.Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist2007; 12: 1055–66.
49. Badawy A, Elnashar A, El-Ashry M et al.Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril2009; 91: 694–7.
50. Srkalovic G, Schally AV, Wittliff JL et al.Presence and characteristics of receptors for [D-Trp6] luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer. Int J Oncol1998; 12: 489–98.
51. Emous G, Grndker C, Ganthert AR et al.GnRH antagonists in the treatment of gynaecological and breast cancer. Endocr-Relat Cancer2003; 10: 291–9.
52. Blumenfeld Z, Shapiro D, Shteinberg M et al.Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus2000; 9: 401–5.
53. Gonfloni S, Di Tella L, Caldarola S et al.Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med2009; 15: 1179–85.
54. Varghese A, du Plessis S, Falcone T et al.Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation. Reprod Biol Endocrimol2008; 6: 47.
55. Chian RC, Huang JY, Gilbert L et al.Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril2009; 91: 2391–8.
56. Buckett WM, Chian RC, Dean NL et al.Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril2008; 90: 546–50.
57. Bernatsky S, Clarke A and Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med2008; 168: 378–81.
58. Langford C. Wegener’s granulomatosis: current and upcoming therapies. Arthritis ResTher2003; 5: 180–91.
59. Schroeder JO, Euler H and Loffler H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythemathosus.Ann InternMed1987; 107: 344–6.
60. Manger K, Wildt L, Kalden JR et al.Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev2006; 5: 269–72.
61. Buyon JP, Petri MA, Kim MY et al.The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med2005; 142: 953–62.
62. García-Velasco JA, Moreno L, Pacheco A et al.Aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril2005; 84: 82–7.
63. Oktay K, Hourvitz A, Sahin G et al.Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metabol2006; 91: 3885–90.
64. Dupas C and Christin-Maitre S. What are the factors affecting fertility in 2008? Ann Endocrinol2008; 69 (Suppl. 1): S57–61.
65. Somigliana E, Ragni G, Benedetti F et al.Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod2003; 18: 2450–3.
66. García-Velasco JA and Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod2009; 24: 496–501.
67. Muzii L, Bellati F, Bianchi A et al.Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Hum Reprod2005; 20: 1987–92.
68. Busacca M and Vignali M. Endometrioma excision and ovarian reserve: a dangerous relation. J Minim Invasive Gynecol2009; 16: 142–8.
69. Rauck AM and Grouas AC. Bone marrow transplantation in adolescents. Adolesc Med1999; 10: 445–9.
70. Lau NM, Huang JY, MacDonald S et al.Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online2009; 18: 290–5.
71. Pienkowski C, Menendez M, Cartault A et al.Turner’s syndrome and procreation. Ovarian function and Turner’s syndrome. Gynecol Obstet Fertil2008; 36: 1030–4.
72. Tropé C, Davidson B, Paulsen T et al.Diagnosis and treatment of borderline ovarian neoplasms “the state of the art.” Eur J Gynaecol Oncol2009; 30: 471–82.
73. Morice P, Camatte S, El Hassan J et al.Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril2001; 75: 92–6.
74. Koskas M, Madelenat P and Yazbeck C. Ovarian low malignant potential tumor: how to preserve fertility? Gynecol Obstet Fertil2009; 37: 942–50.
75. Cobo A, Bellver J, Domingo J et al.New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online2008; 17: 68–72.